MiR-122-5p inhibits cell migration and invasion in gastric cancer by down-regulating DUSP4

References

• Van Cutsem E, Sagaert X, Topal B, Haustermans K, Prenen H. Gastric cancer. Lancet. 2016;388:2654–64. doi:10.1016/S0140-6736(16)30354-3.
   PubMed Web of Science ®Google Scholar
• Li L, Ying XJ, Sun TT, Yi K, Tian HL, Sun R, Tian JH, Yang KH. Overview of methodological quality of systematic reviews about gastric cancer risk and protective factors. Asian Pac J Cancer Prev: APJCP. 2012;13:2069–79. doi:10.7314/APJCP.2012.13.5.2069.
   PubMed Web of Science ®Google Scholar
• Kato M, Asaka M. Recent knowledge of the relationship between Helicobacter pylori and gastric cancer and recent progress of gastroendoscopic diagnosis and treatment for gastric cancer. Jpn J Clin Oncol. 2010;40:828–37. doi:10.1093/jjco/hyq119.
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ, He J. Cancer statistics in China, 2015. CA: a cancer journal for clinicians. 2016;66:115–32.
   PubMed Web of Science ®Google Scholar
• Zheng L, Jiao W, Song H, Qu H, Li D, Mei H, Chen Y, Yang F, Li H, Huang K, et al. miRNA-558 promotes gastric cancer progression through attenuating Smad4-mediated repression of heparanase expression. Cell Death Dis. 2016;7:e2382. doi:10.1038/cddis.2016.293.
   PubMed Web of Science ®Google Scholar
• Chia NY, Tan P. Molecular classification of gastric cancer. Ann Oncol: official journal of the European Society for Medical Oncology. 2016;27:763–9. doi:10.1093/annonc/mdw040.
   PubMed Web of Science ®Google Scholar
• Tsai MM, Wang CS, Tsai CY, Huang HW, Chi HC, Lin YH, Lu PH, Lin KH. Potential Diagnostic, Prognostic and Therapeutic Targets of MicroRNAs in Human Gastric Cancer. Int J Mol Sci. 2016;17. doi:10.3390/ijms17060945.
   Web of Science ®Google Scholar
• Sundaram P, Hultine S, Smith LM, Dews M, Fox JL, Biyashev D, Schelter JM, Huang Q, Cleary MA, Volpert OV, et al. p53-responsive miR-194 inhibits thrombospondin-1 and promotes angiogenesis in colon cancers. Cancer Res. 2011;71:7490–501. doi:10.1158/0008-5472.CAN-11-1124.
   PubMed Web of Science ®Google Scholar
• Bar-Eli M. Searching for the ‘melano-miRs’: miR-214 drives melanoma metastasis. EMBO J. 2011;30:1880–1. doi:10.1038/emboj.2011.132.
   PubMed Web of Science ®Google Scholar
• An Y, Zhang Z, Shang Y, Jiang X, Dong J, Yu P, Nie Y, Zhao Q. miR-23b-3p regulates the chemoresistance of gastric cancer cells by targeting ATG12 and HMGB2. Cell Death Dis. 2015;6:e1766. doi:10.1038/cddis.2015.123.
   PubMed Web of Science ®Google Scholar
• Zhang X, Zeng J, Zhou M, Li B, Zhang Y, Huang T, Wang L, Jia J, Chen C. The tumor suppressive role of miRNA-370 by targeting FoxM1 in acute myeloid leukemia. Mol Cancer. 2012;11:56. doi:10.1186/1476-4598-11-56.
   PubMed Web of Science ®Google Scholar
• Zhu M, Zhang N, He S, Lui Y, Lu G, Zhao L. MicroRNA-106a targets TIMP2 to regulate invasion and metastasis of gastric cancer. FEBS Lett. 2014;588:600–7. doi:10.1016/j.febslet.2013.12.028.
   PubMed Web of Science ®Google Scholar
• Miko E, Margitai Z, Czimmerer Z, Varkonyi I, Dezso B, Lanyi A, Bacsó Z, Scholtz B. miR-126 inhibits proliferation of small cell lung cancer cells by targeting SLC7A5. FEBS Lett. 2011;585:1191–6. doi:10.1016/j.febslet.2011.03.039.
   PubMed Web of Science ®Google Scholar
• Chen Q, Ge X, Zhang Y, Xia H, Yuan D, Tang Q, Chen L, Pang X, Leng W, Bi F. Plasma miR-122 and miR-192 as potential novel biomarkers for the early detection of distant metastasis of gastric cancer. Oncol Rep. 2014;31:1863–70. doi:10.3892/or.2014.3004.
   PubMed Web of Science ®Google Scholar
• Lu W, Zhang Y, Zhou L, Wang X, Mu J, Jiang L, Hu Y, Dong P, Liu Y. miR-122 inhibits cancer cell malignancy by targeting PKM2 in gallbladder carcinoma. Tumour Biol. 2015. doi:10.1007/s13277-015-4308-z.
   Google Scholar
• Wang Y, Xing QF, Liu XQ, Guo ZJ, Li CY, Sun G. MiR-122 targets VEGFC in bladder cancer to inhibit tumor growth and angiogenesis. Am J Transl Res. 2016;8:3056–66.
   PubMed Web of Science ®Google Scholar
• Ergun S, Ulasli M, Igci YZ, Igci M, Kirkbes S, Borazan E, Balik A, Yumrutaş Ö, Camci C, Cakmak EA, et al. The association of the expression of miR-122-5p and its target ADAM10 with human breast cancer. Mol Biol Rep. 2015;42:497–505. doi:10.1007/s11033-014-3793-2.
   PubMed Web of Science ®Google Scholar
• Bai S, Nasser MW, Wang B, Hsu SH, Datta J, Kutay H, Yadav A, Nuovo G, Kumar P, Ghoshal K, et al. MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib. J Biol Chem. 2009;284:32015–27. doi:10.1074/jbc.M109.016774.
   PubMed Web of Science ®Google Scholar
• Patterson KI, Brummer T, O'Brien PM, Daly RJ. Dual-specificity phosphatases: critical regulators with diverse cellular targets. Biochem J. 2009;418:475–89. doi:10.1042/BJ20082234.
   PubMed Web of Science ®Google Scholar
• Huang CY, Tan TH. DUSPs, to MAP kinases and beyond. Cell Biosci. 2012;2:24. doi:10.1186/2045-3701-2-24.
   PubMed Web of Science ®Google Scholar
• Zhang R, Wang G, Zhang PF, Zhang J, Huang YX, Lu YM, Da W, Sun Q, Zhu JS. Sanguinarine inhibits growth and invasion of gastric cancer cells via regulation of the DUSP4/ERK pathway. J Cell Mol Med. 2017;21:1117–27. doi:10.1111/jcmm.13043.
   PubMed Web of Science ®Google Scholar
• De Vriendt V, De Roock W, Di Narzo AF, Tian S, Biesmans B, Jacobs B, Budinska E, Sagaert X, Rossi S, D'Ario G, et al. DUSP 4 expression identifies a subset of colorectal cancer tumors that differ in MAPK activation, regardless of the genotype. Biomarkers: biochemical indicators of exposure, response, and susceptibility to chemicals. 2013;18:516–24. doi:10.3109/1354750X.2013.819038.
   PubMed Web of Science ®Google Scholar
• Wei X, Tang C, Lu X, Liu R, Zhou M, He D, Zheng D, Sun C, Wu Z. MiR-101 targets DUSP1 to regulate the TGF-beta secretion in sorafenib inhibits macrophage-induced growth of hepatocarcinoma. Oncotarget. 2015;6:18389–405. doi:10.18632/oncotarget.4089.
   PubMedGoogle Scholar
• Samsonov R, Burdakov V, Shtam T, Radzhabovsmall a CZ, Vasilyev D, Tsyrlina E, Titov S, Ivanov M, Berstein L, Filatov M, et al. Plasma exosomal miR-21 and miR-181a differentiates follicular from papillary thyroid cancer. Tumour Biol: the journal of the International Society for Oncodevelopmental Biology and Medicine. 2016;37:12011–21. doi:10.1007/s13277-016-5065-3.
   PubMedGoogle Scholar
• Zhang H, Sun Z, Li Y, Fan D, Jiang H. MicroRNA-200c binding to FN1 suppresses the proliferation, migration and invasion of gastric cancer cells. Biomed Pharmacother = Biomedecine & pharmacotherapie. 2017;88:285–92.
   PubMed Web of Science ®Google Scholar
• Wang C, Qiao C. MicroRNA-190b confers radio-sensitivity through negative regulation of Bcl-2 in gastric cancer cells. Biotechnol Lett. 2017;39:485–90. doi:10.1007/s10529-016-2273-2.
   PubMed Web of Science ®Google Scholar
• Ding L, Zhang S, Xu M, Zhang R, Sui P, Yang Q. MicroRNA-27a contributes to the malignant behavior of gastric cancer cells by directly targeting PH domain and leucine-rich repeat protein phosphatase 2. J Exp Clin Cancer Res: CR. 2017;36:45. doi:10.1186/s13046-017-0516-2.
   PubMed Web of Science ®Google Scholar
• Mi Y, Zhang D, Jiang W, Weng J, Zhou C, Huang K, Tang H, Yu Y, Liu X, Cui W, et al. miR-181a-5p promotes the progression of gastric cancer via RASSF6-mediated MAPK signalling activation. Cancer Lett. 2017;389:11–22. doi:10.1016/j.canlet.2016.12.033.
   PubMed Web of Science ®Google Scholar
• Cortez-Dias N, Costa MC, Carrilho-Ferreira P, Silva D, Jorge C, Calisto C, Pessoa T, Robalo Martins S, de Sousa JC, da Silva PC, et al. Circulating miR-122-5p/miR-133b Ratio Is a Specific Early Prognostic Biomarker in Acute Myocardial Infarction. Circ J: official journal of the Japanese Circulation Society. 2016;80:2183–91. doi:10.1253/circj.CJ-16-0568.
   PubMed Web of Science ®Google Scholar
• Yao XL, Lu XL, Yan CY, Wan QL, Cheng GC, Li YM. Circulating miR-122-5p as a potential novel biomarker for diagnosis of acute myocardial infarction. Int J Clin Exp Pathol. 2015;8:16014–9.
   PubMed Web of Science ®Google Scholar
• Barajas-Espinosa A, Basye A, Angelos MG, Chen CA. Modulation of p38 kinase by DUSP4 is important in regulating cardiovascular function under oxidative stress. Free Radic Biol Med. 2015;89:170–81. doi:10.1016/j.freeradbiomed.2015.07.013.
   PubMed Web of Science ®Google Scholar
• Schmid CA, Robinson MD, Scheifinger NA, Muller S, Cogliatti S, Tzankov A, Müller A. DUSP4 deficiency caused by promoter hypermethylation drives JNK signaling and tumor cell survival in diffuse large B cell lymphoma. J Exp Med. 2015;212:775–92. doi:10.1084/jem.20141957.
   PubMed Web of Science ®Google Scholar
• Kim SY, Han YM, Oh M, Kim WK, Oh KJ, Lee SC, Bae KH, Han BS. DUSP4 regulates neuronal differentiation and calcium homeostasis by modulating ERK1/2 phosphorylation. Stem Cells Dev. 2015;24:686–700. doi:10.1089/scd.2014.0434.
   PubMed Web of Science ®Google Scholar
• Lai AZ, Cory S, Zhao H, Gigoux M, Monast A, Guiot MC, Huang S, Tofigh A, Thompson C, Naujokas M, et al. Dynamic reprogramming of signaling upon met inhibition reveals a mechanism of drug resistance in gastric cancer. Sci Signal. 2014;7:ra38. doi:10.1126/scisignal.2004839.
   PubMed Web of Science ®Google Scholar
• Xu T, Wu X, Chen Q, Zhu S, Liu Y, Pan D, Chen X, Li D. The anti-apoptotic and cardioprotective effects of salvianolic acid a on rat cardiomyocytes following ischemia/reperfusion by DUSP-mediated regulation of the ERK1/2/JNK pathway. PloS One. 2014;9:e102292. doi:10.1371/journal.pone.0102292.
   PubMed Web of Science ®Google Scholar
• Balko JM, Schwarz LJ, Bhola NE, Kurupi R, Owens P, Miller TW, Gómez H, Cook RS, Arteaga CL. Activation of MAPK pathways due to DUSP4 loss promotes cancer stem cell-like phenotypes in basal-like breast cancer. Cancer Res. 2013;73:6346–58. doi:10.1158/0008-5472.CAN-13-1385.
   PubMed Web of Science ®Google Scholar